Hoth Therapeutics forms wholly-owned subsidiary merveille.ai for AI-driven drug discovery in rare diseases

Hoth Therapeutics, Inc.

Filed Articles of Incorporation in Nevada for merveille.ai on October 4, 2023.
Subsidiary focuses on drug discovery for rare diseases using artificial intelligence.
merveille.ai is a wholly-owned subsidiary of Hoth Therapeutics.

item 8.01 item 9.01

Hoth Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001013762-23-002005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.